This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists | MicrobiomeTrials
← Back to trials NCT02112565
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2017-01-09Est. Completion: 2018-11-23
Enrollment target: 12 participantsLocations City of Hope Medical Center, Duarte, California, United States Other microbiome trials you might be interested in Unspecified Adult Solid Tumor, Protocol Specific
This pilot randomized clinical trial studies palliative care intervention in improving quality of life, psychological di…
Duarte, United States Completed May 18, 2020
Unspecified Adult Solid Tumor, Protocol Specific
RATIONALE: Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by b…
Duarte, United States Completed Jun 16, 2011